opioid use disorder – Boomerang Ventures

In The news

Boomerang Ventures Commits $1M to Fuel Sonara Health’s Hybrid Methadone Platform Expansion

Source: Tech Point
Boomerang Ventures has invested $1 million in Sonara Health, a Dallas-based health tech company, to scale its hybrid methadone treatment platform nationwide. The platform combines in-person care with virtual tools — including a Virtual Dosing Window™ that lets patients scan QR codes and record dose videos — aiming to reduce daily clinic visits, enhance adherence, and improve outcomes for those with opioid use disorder.

09/23/2025

In The news

Boomerang Ventures Injects $1M into Sonara Health to Expand Hybrid Methadone Care Nationwide

Source: Business Insider
Boomerang Ventures has poured $1 million into Sonara Health, supporting the scale-up of a hybrid methadone care model that blends in-person treatment with digital tools to improve access, retention, and adherence across opioid treatment programs.

09/23/2025

In The news

Sonara Receives Strategic Funding

Source: FinSMEs
Sonara, a Dallas-based hybrid care platform improving access and adherence to methadone treatment, secured strategic funding from leading investors including Acumen America, Sorenson Impact Foundation, Oakwood Circle Ventures, Boomerang Ventures, and First Trust Capital Partners.

08/25/2025

BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.

Boomerang Ventures Commits $1M to Fuel Sonara Health’s Hybrid Methadone Platform Expansion

Boomerang Ventures Injects $1M into Sonara Health to Expand Hybrid Methadone Care Nationwide

Sonara Receives Strategic Funding

HEADQUARTERS

CONNECT

[email protected]

[email protected]

SIGN-UP FOR BOOMERANG UPDATES